Delivery Order SPE2DB24D1006-SPE2DB25FCEYJ
- Not listed
- The Defense Logistics Agency awarded a $1,187.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE 1 mg/0.2 mL kits on July 30, 2025, with completion scheduled for July 31, 2025. This award was not set-aside and represents a competitively awarded transaction under AmerisourceBergen's larger contract vehicle with DLA. GVOKE is a glucagon emergency injection kit used for treating severe hypoglycemia in patients with diabetes, making this a critical pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 27, 2025, for the supply of Glucagon 1 mg Emergency Kits, with a ceiling value of $3,722.88. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,557.64 to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency kits. The contract, executed on July 22, 2025, with an ultimate completion date of July 23, 2025, is a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypopenTM auto-injector units (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $19,036.29. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contract specifies performance at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.87 to AmerisourceBergen Drug Corp for Glucagon 1 mg Emergency Kits on July 21, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) with a ceiling value of $3,737.84 under a firm fixed price contract type. The delivery order was non-competitive with no set-aside designation and carries an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency kits, with a contract ceiling value of $7,809.84. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed-price pricing under a non-competitive set-aside arrangement. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,368.20 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Glucagon 1 mg Emergency Kits. This firm fixed-price contract, issued without set-aside designation, is scheduled for completion by August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a $2,955.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits, with an ultimate completion date of August 1, 2025. The award was issued on July 31, 2025, with no set-aside designation, indicating competitive selection. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its Corporate Office location. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,163.09 to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits, with an ultimate completion date of July 30, 2025. This contract utilizes firm fixed pricing and was awarded competitively with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEYJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,012.14 to AmerisourceBergen Drug Corp for GVOKE 1 MG/0.2 ML emergency glucagon kits on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child delivery order under a larger contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The underlying contract encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and comprehensive pharmaceutical procurement capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/28/25 |